KR100963339B1 - Anti-peptic ulcer preparation comprising rice prolamin - Google Patents

Anti-peptic ulcer preparation comprising rice prolamin Download PDF

Info

Publication number
KR100963339B1
KR100963339B1 KR1020080030917A KR20080030917A KR100963339B1 KR 100963339 B1 KR100963339 B1 KR 100963339B1 KR 1020080030917 A KR1020080030917 A KR 1020080030917A KR 20080030917 A KR20080030917 A KR 20080030917A KR 100963339 B1 KR100963339 B1 KR 100963339B1
Authority
KR
South Korea
Prior art keywords
extract
glutinous rice
ulcer
prolamin
fraction
Prior art date
Application number
KR1020080030917A
Other languages
Korean (ko)
Other versions
KR20090105460A (en
Inventor
안봉환
송동업
장미선
정영도
양성렬
최기오
신부안
Original Assignee
다산엠앤에프(주)
전남대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다산엠앤에프(주), 전남대학교산학협력단 filed Critical 다산엠앤에프(주)
Priority to KR1020080030917A priority Critical patent/KR100963339B1/en
Priority to CN2009801120968A priority patent/CN101983053B/en
Priority to JP2011502850A priority patent/JP2011516467A/en
Priority to PCT/KR2009/001544 priority patent/WO2009145424A2/en
Publication of KR20090105460A publication Critical patent/KR20090105460A/en
Application granted granted Critical
Publication of KR100963339B1 publication Critical patent/KR100963339B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998Hordeum (barley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

본 발명은 쌀 프롤라민(prolamin)을 활성성분으로 포함하는 것을 특징으로 하는 항소화성 궤양 조성물에 관한 것이다.The present invention relates to an anti-extinguishing ulcer composition comprising rice prolamin (prolamin) as an active ingredient.

본 발명의 항소화성 궤양 조성물은 소화성 궤양에 있어서 탁월한 예방 또는 치료효과를 가질 뿐만 아니라 상용식품의 단백질을 활성성분으로 포함함으로써 안전성이 높아 광범위하게 이용될 수 있다.The anti-digestive ulcer composition of the present invention can be widely used because of high safety by including a protein of a commercial food as an active ingredient as well as having an excellent prophylactic or therapeutic effect in peptic ulcer.

프롤라민, 쌀, 단백질, 항소화성궤양 Prolamin, Rice, Protein, Anti-Peptic Ulcer

Description

쌀 프롤라민을 포함하는 항소화성궤양 조성물{ANTI-PEPTIC ULCER PREPARATION COMPRISING RICE PROLAMIN}Antidigestive ulcer composition comprising rice prolamin {ANTI-PEPTIC ULCER PREPARATION COMPRISING RICE PROLAMIN}

본 발명은 쌀 프롤라민을 활성성분으로서 포함하는 항소화성 궤양 조성물; 및 쌀 프롤라민을 활성성분으로 포함하고, 차추출물, 수삼추출물, 보리추출물, (-)-에피카테킨(EC), 탄닌산 및 시스테인으로 이루어진 군으로부터 선택된 1종 이상을 활성촉진 보조성분으로서 추가로 포함하는 항소화성 궤양 조성물에 관한 것이다.The present invention provides an anti-digestive ulcer composition comprising rice prolamin as an active ingredient; And rice prolamin as an active ingredient, and further comprising at least one selected from the group consisting of tea extract, ginseng extract, barley extract, (-)-epicatechin (EC), tannic acid, and cysteine as activation promoters It relates to an antidigestive ulcer composition.

소화성 궤양에 대한 약물 치료의 주목적은 통증을 해소하고, 궤양 자체를 치유하는 데 있으며, 부수적으로는 궤양 재발과 합병증을 예방하는 데 있다. 이를 위해 현재 통용되는 항궤양제로서 제산제, H2-수용체 길항제, 수소이온 펌프 억제제, 항 헬리코박터 피로리제 등이 있으나 이들 약제의 대부분이 다양한 부작용을 나타내기 때문에 장기 복용시 주의를 요하고 있다.The main purpose of drug treatment for peptic ulcers is to relieve pain, heal the ulcer itself, and incidentally to prevent ulcer recurrences and complications. To this end, anti-ulcers currently used include antacids, H 2 -receptor antagonists, hydrogen ion pump inhibitors, and anti-helicobacter pylori, but most of these drugs have various side effects.

한편, 본 발명자들은 찹쌀추출물이 효과적으로 위궤양 발생을 억제하며, 발생된 궤양을 치유하는 데 탁월한 효과가 있을 뿐 아니라, 상용식품의 추출물로서 생체에 대한 안전성이 높다는 것을 보고한 바 있다(안 등, 한국특허 제 0208969호, 1999; 안 등, 한국특허 제 0253740호, 2000; 안 등, 한국특허 제 10-0627820호, 2006). 그러나 상기의 발명에서는 찹쌀추출물 중에 존재하는 항궤양 활성물질을 밝혀내지는 못하였다.On the other hand, the present inventors have reported that glutinous rice extract effectively suppresses the occurrence of gastric ulcers, has an excellent effect in healing the ulcers generated, as well as high safety for the living body as an extract of a commercial food (Ahn et al., Korea Patent Nos. 0208969, 1999; Ahn et al., Korean Patent Nos. 0253740, 2000; Ahn et al., Korean Patent No. 10-0627820, 2006). However, the above invention did not reveal the anti-ulcer active substance present in the glutinous rice extract.

본 발명자들은 항소화성 궤양활성을 갖는 성분을 밝히기 위해 계속 연구를 진행한 결과, 찹쌀 또는 멥쌀에 함유된 프롤라민 단백질이 이러한 항소화성 궤양활성을 나타내는 주성분임을 발견함으로써 본 발명을 완성하였다.The present inventors continued the study to identify the components having anti-digestive ulcer activity, and as a result, the present inventors completed the present invention by discovering that the prolamin protein contained in glutinous rice or non-glutinous rice is the main component showing such anti-digestive ulcer activity.

즉, 본 발명의 목적은 우수한 항소화성 궤양활성을 갖는 조성물을 제공하는 것이다.That is, an object of the present invention is to provide a composition having excellent anti-digestive ulcer activity.

상기 목적을 달성하기 위하여, 본 발명에서는 쌀 프롤라민을 활성성분으로서 포함하는 것을 특징으로 하는 항소화성 궤양 조성물을 제공한다.In order to achieve the above object, the present invention provides an anti-extinguishing ulcer composition comprising rice prolamin as an active ingredient.

또한, 본 발명에서는 이러한 쌀 프롤라민을 활성성분으로서 포함하는 항소화성 궤양 조성물에 차추출물, 수삼추출물, 보리추출물, (-)-에피카테 킨(epicatechin), 탄닌산(tannic acid) 및 시스테인(cysteine)으로 이루어진 군으로부터 선택된 1종 이상을 활성촉진 보조성분으로 추가로 포함시킴으로써 항소화성 궤양활성에 대한 상승효과를 수득할 수 있음을 발견하였다. 이러한 활성촉진 보조성분은 쌀 프롤라민 1 중량부에 대하여 1 내지 80 중량부로 포함하는 것이 바람직하다. In addition, in the present invention, an anti-digestive ulcer composition containing such rice prolamin as an active ingredient tea extract, ginseng extract, barley extract, (-)-epicatechin (epicatechin), tannic acid (tannic acid) and cysteine (cysteine) It has been found that synergistic effects on anti-digestive ulcer activity can be obtained by further including one or more selected from the group consisting of The activity promoting auxiliary component is preferably included 1 to 80 parts by weight based on 1 part by weight of rice prolamin.

본 발명의 항소화성 궤양 조성물의 활성성분인 쌀 프롤라민은 찹쌀 또는 멥쌀로부터 정제될 수 있으며, 이와 유사구조를 갖는 프롤라민 유도체도 사용가능하다. Rice prolamin, the active ingredient of the anti-digestive ulcer composition of the present invention, can be purified from glutinous or non-glutinous rice, and prolamin derivatives having a similar structure can be used.

본 조성물은 경구투여용 제형으로 제제화할 수 있으며, 또한 약제학적으로 허용 가능한 담체를 함유할 수 있다.The composition may be formulated in an oral dosage form and may also contain a pharmaceutically acceptable carrier.

본 조성물의 1회 복용량은 체중 Kg당 0.3 내지 3㎎의 찹쌀 프롤라민을 투여하는 것이 바람직하며, 1일 1 내지 10회 복용하는 것이 적당하다. The dose of the present composition is preferably administered 0.3 to 3mg of glutinous rice prolamin per Kg of body weight, preferably 1 to 10 times a day.

본 발명의 쌀 프롤라민을 활성성분으로서 포함하는 조성물은 소화성 궤양에 있어서 우수한 예방 또는 치료효과를 갖는다. The composition comprising the rice prolamin of the present invention as an active ingredient has an excellent prophylactic or therapeutic effect in peptic ulcer.

이하, 본 발명을 하기 실시예 및 시험예를 통하여 더욱 상세히 설명하고자 한다. 단, 하기 실시예 및 시험예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 이들에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples and test examples. However, the following Examples and Test Examples are only for illustrating the present invention, but the scope of the present invention is not limited thereto.

실시예Example 1: 찹쌀추출물 제조 1: production of glutinous rice extract

찹쌀분말 150g에 5배 중량의 증류수를 가하고 믹서기를 사용하여 30초간 3회 진탕하였다. 진탕 후 3,000× g에서 10분간 원심분리하여 상층액을 얻고, 미국 피어스(Pierce)사의 BCA 키트를 사용하여 수득된 상층액의 단백 농도를 측정한 결과 1.42 ㎎/㎖이었다. 이 상층액을 증류수로 희석하여 단백농도가 1㎎/㎖이 되도록 하고 이를 찹쌀추출물로 사용하였다.Five times the weight of distilled water was added to 150 g of glutinous rice powder and shaken three times for 30 seconds using a blender. After shaking, the supernatant was obtained by centrifugation at 3,000 × g for 10 minutes, and the protein concentration of the obtained supernatant was measured using a BCA kit of Pierce, USA, and the result was 1.42 mg / ml. The supernatant was diluted with distilled water so that the protein concentration was 1 mg / ml, which was used as a glutinous rice extract.

실시예Example 2: 찹쌀추출물의 침전분획 및 가용분획 제조 2: Preparation of Sedimentation Fraction and Soluble Fraction of Glutinous Rice Extract

실시예 1에서 제조한 찹쌀추출물 500㎖을 실온에서 15시간 방치하여 침전이 충분히 일어나게 한 후 2,000× g에서 10분간 원심분리하여 침전물과 맑은 액상부분으로 분리하고, 침전물을 500㎖의 증류수에 부유시켜 찹쌀추출물 침전분획으로 사용하였으며, 맑은 액상 부분을 찹쌀추출물 가용분획으로 사용하였다.500 ml of the glutinous rice extract prepared in Example 1 was left at room temperature for 15 hours to allow sufficient precipitation, followed by centrifugation at 2,000 × g for 10 minutes to separate the precipitate into a clear liquid portion, and the precipitate was suspended in 500 ml of distilled water. The glutinous rice extract was used as the precipitation fraction, and the clear liquid portion was used as the glutinous rice extract soluble fraction.

실시예Example 3: 멥쌀추출물과 그의 가용분획 제조 3: Preparation of Non-rice Extract and its Soluble Fraction

실시예 1 및 2에서와 동일한 방법으로 멥쌀추출물의 가용분획을 제조하였다. 즉, 멥쌀 분말 50g에 5배 중량의 증류수를 가하고 믹서기를 사용하여 30초간 3회 진탕 후 3,000× g에서 10분간 원심분리하여 상층액을 얻고, 단백농도가 1㎎/㎖이 되도록 희석하여 이를 멥쌀추출물로 사용하였다. 멥쌀추출물을 실온에서 15시간 방 치하여 침전이 충분히 생기게 한 후에 2,000× g에서 10분간 원심분리하여 상층의 맑은 액상 부분을 멥쌀추출물의 가용분획으로 사용하였다.Soluble fraction of non-rice extract was prepared in the same manner as in Examples 1 and 2. That is, 5 times weight of distilled water was added to 50 g of non-glutinous rice powder, and shaken three times for 30 seconds using a mixer, followed by centrifugation at 3,000 × g for 10 minutes to obtain a supernatant, which was diluted so that the protein concentration was 1 mg / ml. Used as an extract. After the rice extract was left at room temperature for 15 hours to sufficiently precipitate, centrifuged at 2,000 × g for 10 minutes, and the clear liquid portion of the upper layer was used as the soluble fraction of the rice extract.

실시예Example 4: 보리 및 밀 추출물과 그의 가용분획 제조 4: Preparation of Barley and Wheat Extracts and Their Soluble Fractions

보리 및 밀 분말 각각 50g에 5배 중량의 증류수를 가하고 믹서기를 사용하여 30초간 3회 진탕하였다. 진탕 후 3,000× g에서 10분간 원심분리하여 상층액을 얻고 단백농도가 1㎎/㎖이 되도록 희석하여 이를 각각 보리추출물 및 밀추출물로 사용하였다. 상기 추출물의 일부를 다시 15,000× g에서 20분간 원심하여 침전물과 맑은 액상 부분을 분리하고, 맑은 액상 부분을 각각 보리추출물 및 밀추출물의 가용분획으로 사용하였다. Five times the weight of distilled water was added to 50 g of barley and wheat powder, respectively, and shaken three times for 30 seconds using a blender. After shaking, the supernatant was obtained by centrifugation at 3,000 × g for 10 minutes, and the protein concentration was diluted to 1 mg / ml, which was used as barley extract and wheat extract, respectively. A portion of the extract was centrifuged again at 15,000 × g for 20 minutes to separate the precipitate and the clear liquid portion, and the clear liquid portion was used as an soluble fraction of barley extract and wheat extract, respectively.

실시예Example 5: 수삼추출물의 가용분획 제조 5: soluble fraction of fresh ginseng extract

수삼 25g에 10배 중량의 증류수를 가하고 믹서기를 사용하여 30초간 3회 진탕하였다. 진탕 후 15,000× g에서 20분간 원심분리하여 침전물과 맑은 액상 부분을 분리하고, 맑은 액상 부분을 수삼추출물 가용분획으로 사용하였다. Distilled water of 10-fold weight was added to 25 g of fresh ginseng and shaken three times for 30 seconds using a blender. After shaking, centrifugation was carried out at 15,000 × g for 20 minutes to separate the precipitate and the clear liquid portion, and the clear liquid portion was used as a soluble fraction of fresh ginseng extract.

실시예Example 6:  6: 차추출물의Tea extract 가용분획 제조 Soluble fraction manufacturing

녹차 (한국 태평양사, 상품명 : 한라), 홍차 (영국의 Lipton사제), 우롱차 (中國福建 烏龍茶 ) 10g씩을 각각 100배 중량의 끓는 증류수에 넣어 10분간 추출한 다음, 여과하였다. 이후 실험에서는 이 여과액을 그대로 사용하거나, 냉동건조시켜 분말상태 (녹차 약 2.2g, 홍차 약 2.1g, 우롱차 약 2.0g)로 만든 뒤 사용하였다.Green tea (Korean Pacific, trade name: Halla), black tea (made by Lipton, UK), and oolong tea (中國 福建 烏龍 茶) 10g each were put into 100-fold boiling distilled water, extracted for 10 minutes, and filtered. In subsequent experiments, the filtrate was used as it was, or freeze-dried to make a powder (about 2.2g of green tea, about 2.1g of black tea, about 2.0g of oolong tea).

실시예Example 7: 쌀  7: rice 프롤라민Prolamin 정제 refine

찹쌀 및 멥쌀 분말 100g을 증류수 300㎖로 4시간 추출한 다음 2,000× g에서 10분간 원심분리하여 침전물을 얻고, 이상과 같은 증류수 추출과정을 다시 한번 반복하였다. 증류수 추출 후 침전물을 다시 300㎖의 0.5M NaCl로 4시간 추출하고, 동일한 추출 과정을 한번 더 반복하였다.100 g of glutinous rice and non-glutinous rice powder was extracted with 300 ml of distilled water for 4 hours, followed by centrifugation at 2,000 × g for 10 minutes to obtain a precipitate, and the distilled water extraction process was repeated once again. After distilled water extraction, the precipitate was extracted again with 300 ml of 0.5 M NaCl for 4 hours, and the same extraction process was repeated once more.

상기 과정을 통해 얻은 침전물을 300㎖의 2-프로판올로 1시간동안 추출하고, 동일한 추출 과정을 한번 더 반복하였다. 2-프로판올 추출액을 합하고 여과한 다음 후드에서 건조시켰다. The precipitate obtained through the above procedure was extracted with 300 ml of 2-propanol for 1 hour, and the same extraction procedure was repeated once more. The 2-propanol extracts were combined, filtered and dried in the hood.

상기 건조물을 50㎖의 70% 에탄올에 충분히 녹인 다음 여과하였다. 여과액에 3배 용량의 냉(冷) 아세톤을 천천히 가하여 단백침전이 충분히 생기도록 하고 2,000× g에서 20분간 원심분리하여 침전물을 얻었다. 침전물을 다시 30㎖의 70% 에탄올에 녹이고 3배 용량의 냉 아세톤으로 침전시키는 과정을 2번 더 반복한 뒤, 침전물을 증류수로 24시간 투석하였다. 상기 과정을 거쳐 각각 62㎎과 85㎎의 찹쌀과 멥쌀 프롤라민을 얻었다.The dried material was sufficiently dissolved in 50 ml of 70% ethanol and filtered. Three times the volume of cold acetone was slowly added to the filtrate to allow sufficient protein precipitation and centrifugation at 2,000 × g for 20 minutes to obtain a precipitate. The precipitate was again dissolved in 30 ml of 70% ethanol and precipitated with three times the volume of cold acetone two more times, and the precipitate was dialyzed with distilled water for 24 hours. Through the above procedure, 62 mg and 85 mg of glutinous rice and non-glutinous prolamin were obtained, respectively.

실험예Experimental Example 1:  One: 쌀추출물에In rice extract 존재하는  Present 항소화성Antidigestibility 궤양 활성물질 동정( Identification of ulcer active substance 同定同 定 ))

(1) (One) 항소화성Antidigestibility 궤양 효과 측정 방법 How to Measure Ulcer Effects

야마사키(Yamasaki) 등(Eur. J. Pharmacol. 142, 23-29, 1987)이 기술한 방 법을 응용하여 항소화성 궤양 효과를 측정하였다. 즉, 체중 250± 20g의 수컷 흰쥐(Sprague-Dawley)에게 에탄올 1㎖를 경구 투여하여 위궤양을 유발시켰다. 항소화성 궤양 조성물의 활성을 측정하기 위해 에탄올 투여 30분 전에 시험조성물 1㎖를 경구 투여하였다. 에탄올 투여 후 1.5시간에 에테르 마취하에 개복하여 위를 절취하고 절취한 위에 1% 포르말린 10㎖를 주입한 뒤 30분간 고정하였다. 대조군으로서 증류수를 사용하였다. 포르말린 고정 후 위를 대만곡을 따라 절개하고 위 내부 표면을 디지털카메라로 촬영한 다음, 확대한 사진 이미지상(上)에서 면적측정(planimetry)법으로 위점막 손상 부위의 면적을 측정하였다. 위점막의 손상정도는 위궤양 지수로 표시하였는데, 이는 위점막 전체 면적에 대한 손상부위 면적의 백분율이다. 항소화성 궤양 조성물의 위궤양 억제율(%)은 하기 수학식 1과 같이 산출하였다:Anti-inflammatory ulcer effects were measured using the method described by Yamasaki et al. (Eur. J. Pharmacol. 142, 23-29, 1987). That is, gastric ulcers were induced by oral administration of 1 ml of ethanol to a male rat (Sprague-Dawley) weighing 250 ± 20 g. To measure the activity of the antidigestive ulcer composition, 1 ml of the test composition was administered orally 30 minutes before ethanol administration. After 1.5 hours of ethanol administration, the stomach was excised under ether anesthesia, and 10 ml of 1% formalin was injected and fixed for 30 minutes. Distilled water was used as a control. After formalin fixation, the stomach was cut along the Taiwanese gland, the inner surface of the stomach was taken with a digital camera, and the area of the gastric mucosal injury was measured by planimetry on the enlarged photographic image. The degree of damage to the gastric mucosa was expressed by the gastric ulcer index, which is the percentage of the area of injury to the total area of the gastric mucosa. Gastric ulcer inhibition rate (%) of the anti-digestive ulcer composition was calculated by the following equation:

항소화성 궤양 조성물의 위궤양 억제율(%) =[(증류수 대조군의 위궤양지수 - 시험군의 위궤양지수) / 증류수 대조군의 위궤양지수] X 100%% Of gastric ulcer inhibition rate of antidigestive ulcer composition = [(gastric ulcer index of distilled water control group-gastric ulcer index of test group) / gastric ulcer index of distilled water control group] X 100%

측정된 결과에 대한 통계학적 유의성 검증은 일원 분산분석(one-way ANOVA)과 쉐페 검정(Scheffe test)에 따라 수행하였다.Statistical significance verification of the measured results was performed according to one-way ANOVA and Scheffe test.

(2) (2) 쌀추출물과Rice Extract 다른 곡물추출물의  Other grain extracts 항소화성Antidigestibility 궤양 활성 비교 Ulcer activity comparison

실시예 1, 3 및 4에서 제조한 찹쌀추출물, 멥쌀추출물, 보리추출물, 밀추출 물의 항소화성 궤양 활성을 비교하기 위해, 이들 추출물 1㎖씩을 해당 실험군의 흰쥐에 경구 투여하고, 30분후에 에탄올 1㎖씩을 흰쥐에 경구 투여하여 위궤양 발생정도를 측정하였으며, 그 결과는 도 1에 나타내었다. 각 실험군의 흰쥐의 수는 6마리로 하였고, 측정값은 평균± 표준편차로 나타내었으며, **p<0.01은 증류수 대조군에 대한 차의 유의성을 나타낸다.In order to compare the anti-digestive ulcer activity of the glutinous rice extract, non-rice extract, barley extract, and wheat extract prepared in Examples 1, 3 and 4, 1 ml of these extracts were orally administered to the rats of the experimental group, and after 30 minutes, ethanol 1 The amount of gastric ulcer was measured by oral administration to the rats, and the results are shown in FIG. 1. The number of rats in each experimental group were to 6, measured values were expressed as mean ± standard deviation, ** p <0.01 represents the significance of the difference for the control group distilled water.

도 1에서 보듯이, 찹쌀추출물이 가장 강한 항소화성 궤양 활성을 나타내었으며, 멥쌀추출물도 비록 찹쌀추출물 보다는 낮았으나 뚜렷한 항소화성 궤양 활성을 나타내었다. 그러나, 보리추출물과 밀추출물은 유의한 항소화성 궤양 활성을 나타내지 않았다.As shown in FIG. 1, glutinous rice extract showed the strongest anti-digestive ulcer activity, and non-glutinous rice extract showed a pronounced anti-digestive ulcer activity, although lower than glutinous rice extract. However, barley extract and wheat extract did not show significant antidigestive ulcer activity.

(3) 찹쌀추출물의 침전분획과 가용분획 중의 (3) Precipitation and Soluble Fraction of Glutinous Rice Extract 항소화성Antidigestibility 궤양 활성 분포 Ulcer activity distribution

상기 실험결과 찹쌀추출물의 항소화성 궤양 활성이 가장 현저하였으므로 이후 실험에서는 찹쌀추출물을 주대상으로 찹쌀추출물 중의 항소화성 궤양 활성 물질을 동정하고자 하였다. 우선 찹쌀추출물의 항소화성 궤양 활성이 침전분획과 가용분획 중 어디에 존재하는지를 알기 위하여 실시예 1에서 제조한 찹쌀추출물과 실시예 2에서 제조한 찹쌀추출물의 두 분획을 1㎖씩 해당 실험군의 흰쥐에 경구 투여하고, 30분후에 에탄올 1㎖씩을 흰쥐에 경구 투여하여 위궤양 발생정도를 측정하였다. 대조군으로 증류수를 사용하였다. 그 결과를 도 2에 나타내었다. 각 실험군의 흰쥐의 수는 6마리였고, 측정값은 평균± 표준편차로 나타내었으며, p<0.05 및 **p<0.01은 각각 증류수 대조군에 대한 차의 유의성을 나타내며 †† p<0.01은 찹쌀추출물 투여군에 대한 차의 유의성을 나타낸다.The anti-inflammatory ulcer activity of glutinous rice extract was the most prominent, and in the following experiments, we tried to identify the anti-digestive ulcer active substances in the glutinous rice extract. First, in order to know whether the anti-digestive ulcer activity of the glutinous rice extract is present in the precipitate fraction and the soluble fraction, two portions of the glutinous rice extract prepared in Example 1 and the glutinous rice extract prepared in Example 2 were orally added to the rats of the experimental group. After 30 minutes, 1 ml of ethanol was orally administered to the rats, and the incidence of gastric ulcer was measured. Distilled water was used as a control. The results are shown in FIG. The number of rats in each experimental group was 6, and the mean value was expressed as the mean ± standard deviation. p <0.05 and ** p <0.01 represent the difference of the difference with respect to the distilled water control, respectively. †† p <0.01 is the glutinous rice. The significance of the difference with respect to the extract administration group is shown.

도 2에서 보듯이, 증류수 대조군, 찹쌀추출물 투여군, 침전분획 투여군, 가용분획 투여군의 평균 위궤양 지수는 각각 66.5 ± 10.4, 16.0 ± 8.9, 46.3 ± 10.7 및 61.5 ± 11.7%이고, 이로부터 3개 시험군의 위궤양 억제율을 환산하면 각각 75.9% 30.4% 및 7.5%이었다. 즉, 침전분획에서는 찹쌀추출물의 40% 정도의 항소화성 궤양 활성이 나타난 반면, 가용분획에서는 유의한 항소화성 궤양 활성이 나타나지 않았다. 이상의 결과는 찹쌀추출물의 항소화성 궤양 활성을 나타내는 주성분이 침전분획에 존재하나, 그 단독으로는 최대 활성을 나타내지 못하고 그를 위해서는 가용분획에 존재하는 보조성분의 도움을 필요로 할 가능성을 시사한 것이다.As shown in Figure 2, the average gastric ulcer index of the distilled water control group, glutinous rice extract group, sediment fraction fraction group, soluble fraction administration group is 66.5 ± 10.4, 16.0 ± 8.9, 46.3 ± 10.7 and 61.5 ± 11.7%, respectively, from three test groups Gastric ulcer inhibition rate was 75.9% 30.4% and 7.5%, respectively. In other words, the precipitate fraction showed about 40% anti-inflammatory ulcer activity of glutinous rice extract, whereas the soluble fraction did not show significant anti-digestive ulcer activity. The above results suggest that the main ingredient showing the anti-digestive ulcer activity of the glutinous rice extract is present in the sedimentation fraction, but does not show the maximum activity alone, and for that purpose, it is possible to require the assistance of the auxiliary ingredient present in the soluble fraction.

(4) 찹쌀추출물 침전분획의 (4) Sedimentation fraction of glutinous rice extract 항소화성Antidigestibility 궤양활성에 대한 여러 물질의 촉진 효과 Promotional Effects of Various Substances on Ulcer Activity

찹쌀추출물의 가용분획 대신 다른 곡물이나 천연식품의 추출물의 가용분획으로 찹쌀추출물 침전분획의 항소화성 궤양 활성을 촉진시킬 수 있는지 살펴보기 위해 실시예 3 내지 6에서 제조한 멥쌀, 보리, 수삼 및 차 추출물의 가용분획을 찹쌀추출물 침전분획에 첨가하여 항소화성 궤양 활성을 측정하였다. 이를 위해서 실시예 2에서 제조한 찹쌀추출물 침전분획을 원심분리하고 상층액을 버린 다음 상기 첨가물을 가하고 침전분획을 부유시켜 흰쥐에 투여하였다. Non-rice, barley, ginseng and tea extracts prepared in Examples 3 to 6 to see if the soluble fraction of extract of other grains or natural foods can promote the anti-digestive ulcer activity of the glutinous rice precipitate fraction instead of the soluble fraction of glutinous rice extract. Soluble fraction of was added to sedimentation fraction of glutinous rice extract to measure anti-inflammatory ulcer activity. To this end, the glutinous rice extract precipitate prepared in Example 2 was centrifuged, the supernatant was discarded, the additive was added, and the precipitate was suspended and administered to rats.

실험결과, 표 1에 나타낸 바와 같이 멥쌀과 보리같은 곡물 추출물의 가용분 획은 물론 수삼추출물과 차(녹차, 홍차, 우롱차)추출물의 가용분획도 모두 그 단독으로는 유의한 항소화성 궤양활성을 나타내지 않으면서 찹쌀추출물 침전분획의 항소화성 궤양 활성을 촉진시켰으며, 그 중 차추출물의 효과가 가장 뚜렷하였다.As a result, as shown in Table 1, soluble fractions of grain extracts such as rice and barley, as well as soluble fractions of fresh ginseng extract and tea (green tea, black tea, oolong tea) extracts alone showed significant anti-inflammatory ulcer activity. Without promoting the anti-inflammatory ulcer activity of the sediment fraction of glutinous rice extract, the effect of tea extract was the most pronounced.

차추출물 중의 어떤 성분이 이상의 촉진효과를 나타내는 지를 알아보기 위하여 가능성이 높은 물질을 찹쌀추출물 침전분획에 첨가하여 항소화성 궤양활성을 측정하였다.In order to determine which components in the tea extracts exhibited the above facilitating effect, anti-inflammatory ulcer activity was measured by adding a highly likely substance to the glutinous rice extract precipitation fraction.

실험결과, 표 2에 나타낸 바와 같이 각각 10mM 농도의 (-)-에피카테킨(EC), 탄닌산 및 시스테인이 찹쌀추출물 침전분획의 항소화성 궤양활성을 현저히 촉진시킴을 알 수 있었다. 반면, 다른 아미노산을 비롯한 아스코르브산, 환원형 글루타티온, (-)-에피갈로카테킨 갈레이트(EGCG), 피트산, 갈산, 카페인 등은 10mM 농도에서 뚜렷한 촉진 효과를 나타내지 않았다. As a result, as shown in Table 2, (-)-epicatechin (EC), tannic acid, and cysteine at concentrations of 10 mM each significantly promoted the anti-digestive ulcer activity of the glutinous rice extract precipitation fraction. On the other hand, ascorbic acid, reduced glutathione, (-)-epigallocatechin gallate (EGCG), phytic acid, gallic acid, caffeine, etc., including other amino acids, did not show a clear promoting effect at 10 mM concentration.

Figure 112008024072670-pat00001
Figure 112008024072670-pat00001

a 표시한 값은 평균± 표준편차임 a The displayed value is mean ± standard deviation

p<0.05, **p<0.01 : 증류수 대조군에 대한 차의 유의성 p <0.05, ** p <0.01: Significance of difference with distilled water control group

p<0.05, †† p<0.01 : 찹쌀추출물 침전분획 투여군에 대한 차의 유의성 p <0.05, †† p <0.01: Significance of difference between glutinous rice extract and sediment fraction group

Figure 112008024072670-pat00002
Figure 112008024072670-pat00002

a표시한 값은 평균± 표준편차임 a The displayed value is mean ± standard deviation

p<0.05, **p<0.01 : 증류수 대조군에 대한 차의 유의성 p <0.05, ** p <0.01: Significance of difference with distilled water control group

p<0.05 : 찹쌀추출물 침전분획 투여군에 대한 차의 유의성 p <0.05: Significance of tea in glutinous rice extract sediment fraction administration group

(5) 찹쌀추출물 침전분획의 (5) Sedimentation fraction of glutinous rice extract 항소화성Antidigestibility 궤양 활성에 대한 열 처리 및 펩신 처리 효과 Effect of heat treatment and pepsin treatment on ulcer activity

찹쌀추출물 침전분획을 끓는 물에서 5분간 가열 처리하거나, 1% 젖산 존재 하에 0.1㎎/㎖ pepsin과 37℃에서 1시간 반응시키고 소량의 5N NaOH를 가하여 pH 6.8로 교정한 뒤, 각각의 시료에 2㎎/㎖의 녹차추출물을 첨가하고 흰쥐에 투여하여 항소화성 궤양 활성을 측정하였으며, 그 결과는 도 3에 나타내었다. 각 실험군의 흰쥐의 수는 6마리였고, 측정값은 평균± 표준편차로 나타내었으며, **p<0.01은 증류수 대조군에 대한 차의 유의성을 나타내고, †† p<0.01은 가열 또는 펩신처리 전 대조군에 대한 차의 유의성을 나타낸다.The glutinous rice extract precipitate was heated in boiling water for 5 minutes, or reacted with 0.1 mg / ml pepsin for 1 hour at 37 ° C. in the presence of 1% lactic acid, and calibrated to pH 6.8 by adding a small amount of 5N NaOH to each sample. Green tea extract of ㎎ / ㎖ was added and administered to the rats to measure the anti-inflammatory ulcer activity, the results are shown in FIG. The number of rats in each experimental group was 6, and the measured value was expressed as mean ± standard deviation. ** p <0.01 indicates the difference of the difference to the distilled water control group, and †† p <0.01 indicates the control group before heating or pepsin treatment. The significance of the difference for.

도 3에서 보듯이, 찹쌀추출물 침전분획을 고온에서 열처리하거나 펩신으로 처리함에 따라, 침전분획이 지니고 있던 항소화성 궤양 활성을 완전히 상실하였다. 찹쌀추출물 침전분획을 펩신이 첨가되지 않은 1% 젖산과 1시간 반응시킨 후 pH를 중성으로 교정시킨 시험 조성물의 경우에는 처리 전의 항소화성 궤양 활성 대부분을 유지하였다. 이상의 실험결과는 침전분획 중의 항소화성 궤양 활성물질이 가열과 펩신에 의해 쉽게 실활(失活)됨을 가리키고, 이는 활성물질이 단백질일 가능성을 강하게 시사하는 것이다. As shown in FIG. 3, as the glutinous rice extract precipitate fraction was heat-treated at high temperature or treated with pepsin, the anti-digestive ulcer activity of the precipitate fraction was completely lost. In the test composition in which the glutinous rice extract precipitate fraction was reacted with 1% lactic acid without pepsin for 1 hour and then the pH was neutralized, most of the anti-digestive ulcer activity was maintained. The above experimental results indicate that the anti-digestive ulcer active substance in the precipitate fraction is easily inactivated by heating and pepsin, which strongly suggests that the active substance is a protein.

(6) 찹쌀추출물 침전분획 중 글로불린, (6) globulin in sediment fraction of glutinous rice extract, 글루텔린Glutelin  And 프롤라민의Prolamin 항소화성Antidigestibility 궤양 활성 비교 Ulcer activity comparison

찹쌀추출물 침전분획 중에 존재하는 글로불린(globulin), 글루텔린(glutelin) 및 프롤라민 단백질 중 어느 종류가 항소화성 궤양 활성을 나타내는 주성분인지 알아보기 위하여 침전분획을 각기 0.5M NaCl, 1% 젖산, 70% 에탄올로 4시간 추출하고 원심분리 한 다음 추출액과 잔유 침전분획에서 항소화성 궤양 활성을 측정하였으며, 추출액의 경우 증류수에 24시간 투석 후에 시행하였다(도 4). 항소화성 궤양 활성을 측정할 때는 시험 조성물에 2㎎/㎖의 녹차추출물을 첨가하였다. 각 실험군의 흰쥐의 수는 6마리였고, 측정값은 평균±표준편차로 나타내었으며, p<0.05 및 **p<0.01은 각각 증류수 대조군에 대한 차의 유의성을 나타내고, †† p<0.01은 추출전의 찹쌀추출물 침전분획과 녹차추출물 혼합 투여군에 대한 차의 유의성을 나타낸다,In order to determine which of the globulin, glutelin and prolamin proteins in the glutinous rice extract precipitation fractions are the main constituents exhibiting anti-inflammatory ulcer activity, the precipitation fractions were respectively 0.5M NaCl, 1% lactic acid, 70 After extracting with 4% ethanol for 4 hours and centrifuged, the anti-inflammatory ulcer activity was measured in the extract and the precipitate fraction of the residue was carried out after dialysis in distilled water for 24 hours (Fig. 4). When measuring the anti-digestive ulcer activity, 2 mg / ml green tea extract was added to the test composition. The number of rats of each test group was 6, measured values were expressed as mean ± SD, * p <0.05 and ** p <0.01 represents the significance of the difference for each of the distilled water control group, †† p <0.01 was The difference between the precipitated fraction of glutinous rice extract and the green tea extract mixed group before extraction was significant.

도 4에서 보듯이, 0.5M NaCl 또는 1% 젖산으로 추출한 경우에는 항소화성 궤양 활성의 대부분이 침전분획에 남아 있는 반면, 70% 에탄올로 추출하면 항소화성 궤양 활성의 상당 부분이 용출되고 침전분획에는 항소화성 궤양 활성이 뚜렷이 남아 있지 않았다. As shown in FIG. 4, when extracted with 0.5 M NaCl or 1% lactic acid, most of the anti-extinguishing ulcer activity remains in the sediment fraction, while extracting with 70% ethanol elutes a large portion of the anti-digestive ulcer activity. Antidigestive ulcer activity did not remain apparent.

이상의 실험결과는 프롤라민이 찹쌀추출물 침전분획에 존재하는 항소화성 궤양 물질일 가능성을 강하게 시사하는 것이다.The above results strongly suggest the possibility that prolamin is an anti-digestive ulcer in the sediment fraction of glutinous rice extract.

(7) 정제한 찹쌀 (7) refined glutinous rice 프롤라민의Prolamin 항소화성Antidigestibility 궤양 활성 Ulcer activity

찹쌀 프롤라민의 항소화성 궤양 활성을 확인하기 위하여, 찹쌀분말로부터 프롤라민을 정제한 뒤, 그 항소화성 궤양 활성을 측정하였다. 우선 실시예 7에서 찹쌀로부터 정제한 단백질을 램리(Laemmli)의 방법(Nature 192, 680-682, 1970)에 따라 전기영동(SDS-PAGE)하였다. 도 5는 15% 폴리아크릴아미드 겔에 10-30㎍의 단백시료를 가하여 시행한 전기영동 결과이다. 정제한 시료는 분자량이 약 13KDa인 단일 폴리펩타이드 밴드를 나타내고 있으며, 이는 쌀 프롤라민의 구조적 특성과 잘 일치하는 결과이다. 따라서, 실시예 7에서 찹쌀로부터 제조한 시료는 고도로 정제된 프롤라민 단백질임을 확인할 수 있었다.In order to confirm the anti-digestive ulcer activity of glutinous rice prolamin, after purifying the prolamin from glutinous rice powder, the anti-digestive ulcer activity was measured. First, the protein purified from glutinous rice in Example 7 was subjected to electrophoresis (SDS-PAGE) according to the method of Laemmli (Nature 192, 680-682, 1970). FIG. 5 shows the results of electrophoresis performed by adding 10-30 µg of protein samples to 15% polyacrylamide gel. The purified sample showed a single polypeptide band with a molecular weight of about 13 KDa, which is in good agreement with the structural properties of rice prolamin. Therefore, it was confirmed that the sample prepared from glutinous rice in Example 7 was a highly purified prolamine protein.

실시예 7에서 제조한 찹쌀 프롤라민의 항소화성 궤양 활성을 용량 의존적으로 측정하였다(도 6). 이때는 활성촉진 보조성분으로 10mM EC를 첨가하였다. 각 실험군의 흰쥐의 수는 6마리였고, 측정값은 평균± 표준편차로 나타내었으며, p<0.05 및 **p<0.01은 증류수 대조군에 대한 차의 유의성을 나타낸다.The anti-digestive ulcer activity of the glutinous rice prolamin prepared in Example 7 was measured in a dose dependent manner (FIG. 6). At this time, 10mM EC was added as an activation promoter. The number of rats in each experimental group was 6, and the measured value was expressed as mean ± standard deviation, and * p <0.05 and ** p <0.01 indicate the difference of difference with the distilled water control group.

실험결과, 프롤라민의 용량이 동물 체중 Kg당 0.3㎎으로 투여되었을 때부터 유의한 항소화성 궤양 활성을 나타내었고 용량이 증가함에 따라 항소화성 궤양 활성이 증가하다가 체중 Kg당 3㎎에 이르러 최대에 이르렀다.As a result, the dose of prolamin showed significant anti-digestive ulcer activity when administered at 0.3 mg / kg body weight, and the anti-digestive ulcer activity increased with increasing dose, reaching a maximum of 3 mg / kg body weight. .

(8) 정제한 멥쌀 (8) Refined Rice 프롤라민의Prolamin 항소화성Antidigestibility 궤양 활성 Ulcer activity

도 1에서 살펴본 바와 같이 멥쌀추출물에서도 상당한 정도의 항소화성 궤양 활성이 검출되었으므로 찹쌀 프롤라민과 같은 방법으로 멥쌀로부터 프롤라민을 정제하여 그 활성을 살펴보았다. 실시예 7에서 멥쌀로부터 정제한 프롤라민 시료를 전기영동(SDS-PAGE)한 결과(도 7), 분자량이 약 13KDa인 주 폴리펩타이드 밴드를 보였으며, 이는 제조한 단백시료가 고도로 정제된 프롤라민임을 나타내는 결과이다.As shown in FIG. 1, since a considerable amount of anti-digestive ulcer activity was also detected in non-glutinous rice extract, we examined the activity by purifying prolamin from non-glutinous rice by the same method as glutinous rice prolamin. Electrophoresis (SDS-PAGE) of the purified prolamin sample from non-glutinous rice in Example 7 (Fig. 7) showed a major polypeptide band having a molecular weight of about 13 KDa, which produced a highly purified protein sample. Results indicate that it is a rollamine.

또한, 정제한 멥쌀 프롤라민의 항소화성 궤양 활성을 도 6에서와 같은 방법으로 용량 의존적으로 측정한 결과(도 8), 동물 체중 Kg당 3㎎으로 투여하였을 때부터 유의한 활성을 나타내고 용량이 증가함에 따라 항소화성 궤양 활성이 증가하였다. 그러나, 실시예 7에서와 같이 정제한 멥쌀 프롤라민은 찹쌀 프롤라민에 비해 비활성(比活性, specific activity)이 훨씬 낮았다.In addition, as a result of the dose-dependent measurement of the anti-digestive ulcer activity of the purified uncooked rice prolamin as shown in Fig. 6 (Fig. 8), it shows a significant activity from the dose of 3 mg per kg body weight of the animal and the dose is increased As a result, anti-inflammatory ulcer activity increased. However, as in Example 7, purified rice prolamin was much lower in specific activity than glutinous rice prolamin.

도 1은 찹쌀추출물, 멥쌀추출물, 보리추출물 및 밀추출물의 항소화성 궤양활성을 비교한 결과이다.     1 is a result of comparing the anti-inflammatory ulcer activity of glutinous rice extract, non-rice extract, barley extract and wheat extract.

도 2는 찹쌀추출물 전체, 찹쌀추출물의 침전분획, 및 찹쌀추출물의 가용(可溶)분획의 항소화성 궤양활성을 비교한 결과이다.2 is a result of comparing the anti-inflammatory ulcer activity of the whole glutinous rice extract, the sediment fraction of the glutinous rice extract, and the soluble fraction of the glutinous rice extract.

도 3은 찹쌀추출물의 침전분획을 100℃에서 5분간 가열처리 하거나, 단백분해효소인 펩신 처리시의 항소화성 궤양 활성의 변화를 나타낸 것이다. Figure 3 shows the change of anti-digestive ulcer activity during the heat treatment of the precipitate fraction of glutinous rice extract at 100 ° C. for 5 minutes or pepsin treatment.

도 4는 찹쌀추출물의 침전분획을 각각 0.5M NaCl, 1% 젖산(lactic acid), 및 70% 에탄올로 추출했을 때 추출액과 잔유 침전분획에 분포하는 항소화성 궤양 활성을 나타낸 것이다.Figure 4 shows the anti-digestive ulcer activity distributed in the extract and the residue precipitate fraction when the precipitate fraction of glutinous rice extract was extracted with 0.5M NaCl, 1% lactic acid, and 70% ethanol, respectively.

도 5는 찹쌀분말로부터 정제한 프롤라민을 전기영동(SDS-PAGE)한 결과이다.5 is the result of electrophoresis (SDS-PAGE) of the purified prolamin from glutinous rice powder.

도 6은 찹쌀분말로부터 정제한 프롤라민의 용량 의존성 항소화성 궤양 활성을 나타낸 것이다.Figure 6 shows the dose-dependent anti-digestive ulcer activity of prolamine purified from glutinous rice powder.

도 7은 멥쌀분말로부터 정제한 프롤라민을 전기영동(SDS-PAGE)한 결과이다.Figure 7 is the result of electrophoresis (SDS-PAGE) of the purified prolamin from non-glutinous rice powder.

도 8은 멥쌀분말로부터 정제한 프롤라민의 용량 의존성 항소화성 궤양 활성을 나타낸 것이다.Figure 8 shows the dose-dependent anti-digestive ulcer activity of prolamine purified from non-rice powder.

Claims (5)

쌀 프롤라민(prolamin)을 활성성분으로 포함하는 것을 특징으로 하는 항소화성 궤양 조성물.An anti-extinguishing ulcer composition comprising rice prolamin (prolamin) as an active ingredient. 제 1 항에 있어서, The method of claim 1, 차추출물, 수삼추출물, 보리추출물, (-)-에피카테킨(EC), 탄닌산 및 시스테인으로 이루어진 군으로부터 선택된 1종 이상을 활성촉진 보조성분으로서 추가로 포함하는 것을 특징으로 하는 항소화성 궤양 조성물.An anti-digestive ulcer composition further comprising at least one selected from the group consisting of tea extract, ginseng extract, barley extract, (-)-epicatechin (EC), tannic acid, and cysteine as an activation promoter. 제 2 항에 있어서,The method of claim 2, 쌀 프롤라민 1 중량부에 대해 1 내지 80중량부의 활성촉진 보조성분을 포함하는 것을 특징으로 하는 항소화성 궤양 조성물.An anti-extinguishing ulcer composition comprising 1 to 80 parts by weight of an activation promoting ingredient per 1 part by weight of rice prolamin. 제 1 항에 있어서, The method of claim 1, 쌀이 찹쌀 또는 멥쌀인 항소화성 궤양 조성물.An antidigestive ulcer composition wherein the rice is glutinous or non-glutinous. 제 1 항에 있어서, The method of claim 1, 경구투여용 제제로 제제화되는 것을 특징으로 하는 항소화성 궤양 조성물Anti-digestive ulcer composition, characterized in that it is formulated as a preparation for oral administration
KR1020080030917A 2008-04-02 2008-04-02 Anti-peptic ulcer preparation comprising rice prolamin KR100963339B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020080030917A KR100963339B1 (en) 2008-04-02 2008-04-02 Anti-peptic ulcer preparation comprising rice prolamin
CN2009801120968A CN101983053B (en) 2008-04-02 2009-03-26 Anti-peptic ulcer composition comprising rice prolamin
JP2011502850A JP2011516467A (en) 2008-04-02 2009-03-26 Anti-peptic ulcer composition containing rice prolamin
PCT/KR2009/001544 WO2009145424A2 (en) 2008-04-02 2009-03-26 Anti-peptic ulcer composition comprising rice prolamin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080030917A KR100963339B1 (en) 2008-04-02 2008-04-02 Anti-peptic ulcer preparation comprising rice prolamin

Publications (2)

Publication Number Publication Date
KR20090105460A KR20090105460A (en) 2009-10-07
KR100963339B1 true KR100963339B1 (en) 2010-06-14

Family

ID=41377699

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080030917A KR100963339B1 (en) 2008-04-02 2008-04-02 Anti-peptic ulcer preparation comprising rice prolamin

Country Status (4)

Country Link
JP (1) JP2011516467A (en)
KR (1) KR100963339B1 (en)
CN (1) CN101983053B (en)
WO (1) WO2009145424A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016021847A1 (en) * 2014-08-05 2016-02-11 전남대학교산학협력단 Oral anti-atopic composition comprising rice prolamin

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101336411B1 (en) * 2011-05-27 2013-12-04 한국식품연구원 Novel use of rice extract for improving, preventing or treating sleep disorders, anxiety, or depression
CN102335414B (en) * 2011-09-30 2013-07-03 哈尔滨工业大学 Preparation method of rice prolamin bile acid adsorbent
JP6186853B2 (en) * 2013-04-30 2017-08-30 株式会社サタケ Method for recovering protein contained in rice

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100253740B1 (en) 1996-10-23 2000-04-15 Lee Min Hwa A beverage for prevention of ulcer comprising glutinous rice extracts
KR20050122581A (en) * 2004-06-25 2005-12-29 안봉환 Preparation of transparent liquid composition with anti-ulcer activity comprising glutinous rice extract
KR100627820B1 (en) 1999-08-26 2006-09-25 전남대학교산학협력단 A herbal preparation with anti-ulcer activity composed of glutinous rice and tea extracts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3550403B2 (en) * 1990-12-11 2004-08-04 株式会社創研 Anti-ulcer agent
KR100810110B1 (en) * 2001-10-25 2008-03-06 전남대학교산학협력단 Preparation of transparent liquid composition with anti-ulcer activity comprising extracts of glutinous rice and raw ginseng, and process for the preparation thereof
JP2007068454A (en) * 2005-09-06 2007-03-22 Kizakura Co Ltd Method for producing rice protein, rice protein produced by the method, and food
KR100821943B1 (en) * 2007-03-27 2008-04-15 다산엠앤에프(주) Clear liquid anti-ulcer preparations made of glutinous rice and tea extracts

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100253740B1 (en) 1996-10-23 2000-04-15 Lee Min Hwa A beverage for prevention of ulcer comprising glutinous rice extracts
KR100627820B1 (en) 1999-08-26 2006-09-25 전남대학교산학협력단 A herbal preparation with anti-ulcer activity composed of glutinous rice and tea extracts
KR20050122581A (en) * 2004-06-25 2005-12-29 안봉환 Preparation of transparent liquid composition with anti-ulcer activity comprising glutinous rice extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016021847A1 (en) * 2014-08-05 2016-02-11 전남대학교산학협력단 Oral anti-atopic composition comprising rice prolamin

Also Published As

Publication number Publication date
JP2011516467A (en) 2011-05-26
CN101983053A (en) 2011-03-02
KR20090105460A (en) 2009-10-07
WO2009145424A3 (en) 2010-01-21
WO2009145424A2 (en) 2009-12-03
CN101983053B (en) 2012-10-10

Similar Documents

Publication Publication Date Title
Nabavizadeh et al. Gastroprotective effects of Stachys Lavandulifolia extract on experimental gastric ulcer
KR100963339B1 (en) Anti-peptic ulcer preparation comprising rice prolamin
US20140186331A1 (en) Body Weight Gain Suppresing Composition and Food Product Comprising the Same
KR20130035091A (en) Composition for preventing and treating varicocele or male infertility comprising anthocyanin extracted from black soybean
JP5704484B2 (en) Composition comprising Ashwagandha leaf water extract as active ingredient and method for producing the same
Song et al. White tea (Camellia sinenesis (L.)) ethanol extracts attenuate reserpine-induced gastric ulcers in mice
JP7020915B2 (en) Soluble and stable pharmaceutical compositions that are anti-inflammatory, proliferative, protective and mucosal adherent, their use and acquisition methods for treating the condition of mucosal sites, and basic pharmaceutical compositions for the preparation of pharmaceutical compositions. Things and how to get them
KR20200101898A (en) Aqueous extract of artemisia capillaris, and use and preparation method thereof
Stoev et al. Some Indian herbs have protective effects against deleterious effects of ochratoxin A in broiler chicks
KR102247702B1 (en) Composition for preventing or treating gastritis or peptic ulcer
Alkubaisy et al. Evaluation study of the anti-ulcer activities of Cuminum cyminum Seed extract against ethanol-induced gastric ulcer in rats
KR100686260B1 (en) Composition comprising the extract from melandryum firmum for improvement of liver function and treatment of liver diseases
KR20120051904A (en) Making of lacquer tree extract with the function of inhibiting gastritis and gastric ulcer
Salsabila et al. The effectivities of anti-diabetic of Chromolaena odorata L. in lowering blood sugar level: A systematic review
Paharia et al. Evaluation of Anti-ulcer activity of Ethanolic Extract of Nymphaea Alba Linn Flower in experimental rats
Song et al. Protective effect Malus pumila Mill leaf polyphenols in reserpine-induced gastric ulcer in mice
Mahurkar et al. Antiulcer Activity of Commicarpus chinensis in Ethanol and Aspirin Induced Ulcers
KR20160025275A (en) Composition for inhibiting the absorption of fructose and method for the absorption of the fructose
Filimban et al. Evaluation of aqueous extract of Salvadora persica and Glycyrrhiza glabra in treatment of gastric ulcer
Kamer Coşkun et al. Dose-dependent effect of Scolymus hispanicus L.(sevketibostan) on ethylene glycol-induced kidney stone disease in rats
KR102202122B1 (en) Composition for anti-tussive activity or discharge of phlegm activity comprising extract of Atractylodes Rhizome White and Schizandra Fruit
Singh et al. Investigating the Protective Effect of Leaves of Calotropis procera (Aiton) for In-vivo Anti-oxidant and Antiulcer Activity using Pylorus Ligation Method
KR100821943B1 (en) Clear liquid anti-ulcer preparations made of glutinous rice and tea extracts
Kurup et al. Chemopreventive potential of methanolic extract of Leucas aspera against N-nitrosodiethyl amine (NDEA) induced hepatotoxicity in rats
WO2016021847A1 (en) Oral anti-atopic composition comprising rice prolamin

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130524

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140602

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20150529

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180531

Year of fee payment: 9